SCHEMBL6173380

SCHEMBL6173380

CC(c1ccnc(NS(=O)(=O)Cc2ccccc2)c1)C1NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 18/20 0.44
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172754 0.89 IGF1R (0.41) IGF1RKDM4ELMNA
SCHEMBL6174748 0.88 IGF1R (0.43) IGF1R
SCHEMBL6174986 0.87 IGF1R (0.42) IGF1R
SCHEMBL6175884 0.85 IGF1R (0.41) IGF1RLMNA
SCHEMBL6173973 0.84 IGF1R (0.46) IGF1R
SCHEMBL6173796 0.84 IGF1R (0.52) IGF1R
SCHEMBL6174760 0.83 IGF1R (0.41) IGF1R
SCHEMBL6174194 0.83 IGF1R (0.42) IGF1RLMNA
SCHEMBL6177584 0.82 IGF1R (0.38) IGF1RLMNA
SCHEMBL6174695 0.81 LMNA (0.39) IGF1RLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed